Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication

PURPOSE: To investigate risk factors for severe bleeding during warfarin treatment, including the influence of sex, age, comorbidity and co-medication on bleeding risk. METHODS: Patients initiating warfarin treatment between 2007 and 2011 were identified in the nationwide Swedish Prescribed Drug Reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Rydberg, Diana M., Linder, Marie, Malmström, Rickard E., Andersen, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239828/
https://www.ncbi.nlm.nih.gov/pubmed/32222786
http://dx.doi.org/10.1007/s00228-020-02856-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239828/
https://www.ncbi.nlm.nih.gov/pubmed/32222786
http://dx.doi.org/10.1007/s00228-020-02856-6

Ejemplares similares